A groundbreaking discovery has been made by researchers at the Institute of Life Sciences (ILS) in Bhubaneswar. They have identified a novel host protein named NCoR1 (Nuclear Receptor Co-repressor 1), which plays a crucial role in combating severe ailments such as tuberculosis and viral infections and addressing prolonged health complications associated with autoimmune diseases. The research, led by Dr. Sunil Kumar Raghav, revealed that reduced levels of the NCoR1 protein in the body can lead to infections like tuberculosis, while increased amounts help combat the disease. The team’s findings have been published in the international journal PLOS Biology, and ongoing investigations aim to uncover its full functionality in human subjects, with a focus on autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus (SLE).
A groundbreaking discovery has been made by researchers at the Institute of Life Sciences (ILS) in Bhubaneswar. They have identified a novel host protein named NCoR1 (Nuclear Receptor Co-repressor 1), which plays a crucial role in combating severe ailments such as tuberculosis and viral infections and addressing prolonged health complications associated with autoimmune diseases. The research, led by Dr. Sunil Kumar Raghav, revealed that reduced levels of the NCoR1 protein in the body can lead to infections like tuberculosis, while increased amounts help combat the disease. The team’s findings have been published in the international journal PLOS Biology, and ongoing investigations aim to uncover its full functionality in human subjects, with a focus on autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus (SLE).
